Result: 18701 - 18715 of 18715
DRAMP ID Peptide NAME Source Biological Activity SMILES Patent No Patent Title
DRAMP37178 SEQ ID NO: 516 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37179 SEQ ID NO: 517 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37180 SEQ ID NO: 518 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37181 SEQ ID NO: 519 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37182 SEQ ID NO: 520 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37183 SEQ ID NO: 521 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37184 SEQ ID NO: 522 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37185 SEQ ID NO: 523 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37186 SEQ ID NO: 524 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37187 SEQ ID NO: 525 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37188 SEQ ID NO: 526 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37189 SEQ ID NO: 527 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37190 SEQ ID NO: 528 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37191 SEQ ID NO: 529 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
DRAMP37192 SEQ ID NO: 530 of Patent CN110785183A Synthetic Antimicrobial, Anticancer CN110785183A Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Close
Sign in     login

Forgot your password?